化工社化工社 化学情報印刷レポート · 研究参考用
トリメブチン
トリメブチン · 3,4,5-トリメトキシ安息香酸2-ジメチルアミノ-2-フェニルブチル · 3,4,5-トリメトキシ安息香酸2-(ジメチルアミノ)-2-フェニルブチル · トリメブチン BASE · 3,4,5-TRIMETHOXYBENZOIC ACID 2-[DIMETHYLAMINO]-2-PHENYLBUTYL ESTER · Mebutin · TRIMEBUTIN · TRIMEBUTINE

識別子と物理属性
| CAS No. | 39133-31-8 |
|---|---|
| 分子式 | C22H29NO5 |
| 平均分子量 | 387.5 g/mol |
| 単同位体質量 | 387.20457303 g/mol |
| SMILES | CCC(COC(=O)c1cc(OC)c(OC)c(OC)c1)(c1ccccc1)N(C)C |
| InChIKey | LORDFXWUHHSAQU-UHFFFAOYSA-N |
| PubChem CID | 5573 |
| ChEMBL | CHEMBL190044 |
| ChEBI | CHEBI:94458 |
| EC No. | 254-309-2 |
| DTXSID | DTXSID4023707 |
| 現地名 | トリメブチン |
化学・物理的性質
| XLogP | 4 |
|---|---|
| 極性表面積 | 57.2 |
| 水素結合供与体数 | 0 |
| 水素結合受容体数 | 6 |
| 回転可能結合数 | 10 |
| 重原子数 | 28 |
| 形式電荷 | 0 |
| 複雑度 | 466 |
| 溶解度 | Insolubleクロロホルム(微量)、酢酸エチル(微量)、メタノール(微量)10g/L |
| 融点 | 78-8278-80°C |
| Collision Cross Section | 191.12 Ų [M+Na]+ [CCS Type: TWMethod: calibrated with polyalanine and drug standards]177.75 Ų [M+H-H2O]+ [CCS Type: TW197.43 Ų [M+H]+ [CCS Type: TW193.19 Ų [M+K]+ [CCS Type: TW |
| 沸点 | 513.42°C (rough estimate) |
| 密度 | 1.1998 (rough estimate) |
| 屈折率 | 1.5614 (estimate) |
| 貯蔵条件 | 2-8°C |
| 外観・状態 | Solid |
| pKa(酸解離定数) | 7.29±0.50(Predicted) |
| 色 | ホワイトからオフホワイト |
| Merck | 14,9699 |
| 主な用途 | 法医学と毒物学医薬品(低分子化合物)獣医 |
| InChI | 1S/C22H29NO5/c1-7-22(23(2)3,17-11-9-8-10-12-17)15-28-21(24)16-13-18(25-4)20(27-6)19(14-16)26-5/h8-14H,7,15H2,1-6H3 |
| InChIKey | LORDFXWUHHSAQU-UHFFFAOYSA-N |
| SMILES | CCC(COC(=O)c1cc(OC)c(OC)c(OC)c1)(N(C)C)c2ccccc2 |
| CAS データベース | 39133-31-8(CAS DataBase Reference) |
安全性と法規制
| GHS 分類 | This chemical does not meet GHS hazard criteria for 61.5% (8 of 13) of all reports.WarningH302 (23.1%): Harmful if swallowed [Warning Acute toxicity, oral]H312 (30.8%): Harmful in contact with skin [Warning Acute toxicity, dermal]H332 (30.8%): Harmful if inhaled [Warning Acute toxicity, inhalation]H413 (15.4%): May cause long lasting harmful effects to aquatic life [Hazardous to the aquatic environment, long-term hazard]P261, P264, P270, P271, P273, P280, P301+P317, P302+P352, P304+P340, P317, P321, P330, P362+P364, and P501 (click each P-code to see the statement)Aggregated GHS information provided per 13 reports by companies from 5 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.Reported as not meeting GHS hazard criteria per 8 of 13 reports by companies.There are 4 notifications provided by 5 of 13 reports by companies with hazard statement code(s).Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website. |
|---|---|
| 規制情報 | Chemical: Benzoic acid, 3,4,5-trimethoxy-, 2-(dimethylamino)-2-phenylbutyl esterStatus: Active Update: 23-05-2018 https://echa.europa.eu/registration-dossier/-/registered-dossier/25765 |
| Hazard Classes and Categories | Acute Tox. 4 (23.1%)Acute Tox. 4 (30.8%)Aquatic Chronic 4 (15.4%) |
| Drug Induced Liver Injury | Drug-Induced Liver Injury Severity and Toxicity (DILIst)TrimebutineDILI PositiveDOI:10.1016/j.drudis.2019.09.022 |
| 水環境危害等級(WGK) | 3 |
| 税関コード | 2922.19.0900 |
| 貯蔵分類 | 11 - Combustible Solids |
用途
用途
オピオイド作動薬消化管運動調整
使用
Trimebutine is an agonist of peripheral mu, kappa and delta opiate receptors, used as spasmolytic agent for treatment of both acute and chronic abdominal pain.